摘要
《中华肝脏病杂志》2020年核心影响因子为1.807,名列消化病学类期刊第1名,入选中国科学技术协会高质量科技期刊分级目录T1级。2021年获重庆市新闻出版局出版专项资金、重庆市科学技术协会高品质科技期刊资助项目、国家教育部产学研合作协同育人项目支持;获“川渝一流科技期刊”、“重庆市高品质科技期刊”等多项殊荣,实现了期刊“质与量”的双效发展。2022年我们将着力于吸引高水平研究成果,及时、高效、精准传播学术成果,重视数字化传播,建设一流学术期刊。
The Chinese,has a 2020 core impact factor of 1.807,which position it first among the periodicals of gastroenterology.The China Association for Science and Technology classified it as T1 grade and included in the catalogue of high-level scientific and technological periodicals.Since 2021,it has received the special publishing fund of the Chongqing Municipal Bureau of Press and Publications,the High-quality Scientific and Technological Periodicals Funding Project of Chongqing Association for Science and Technology,and the Industry-university-research Cooperation and Collaborative Education Project of the Ministry of Education of the People's Republic of China and won many awards such as"Sichuan-Chongqing First-class Scientific and Technological Periodical"and"Chongqing High-quality Scientific and Technological Periodical",thereby ensuring the development of both qualitative and quantitative effects.Therefore,in 2022,we will work on attracting high-impact research reports,disseminate the academic results timely,efficiently and accurately,highlight the role of digital communication,and pave the way for the establishment of it as a first-class academic journal.
作者
贾继东
任红
Jia Jidong;Ren Hong(Liver Research Center,Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China;Department of Infectious Diseases,the Second Affiliated Hospital of Chongqing Medical University,Institute for Viral Hepatitis,Chongqing Medical University,Chongqing 401336,China)
出处
《中华肝脏病杂志》
CSCD
北大核心
2022年第1期1-3,共3页
Chinese Journal of Hepatology
关键词
寄语
回顾
计划
Message
Review
Plan